143 related articles for article (PubMed ID: 32312836)
1. MTH1 Inhibitor TH588 Disturbs Mitotic Progression and Induces Mitosis-Dependent Accumulation of Genomic 8-oxodG.
Rudd SG; Gad H; Sanjiv K; Amaral N; Hagenkort A; Groth P; Ström CE; Mortusewicz O; Berglund UW; Helleday T
Cancer Res; 2020 Sep; 80(17):3530-3541. PubMed ID: 32312836
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
[TBL] [Abstract][Full Text] [Related]
3. Validation and development of MTH1 inhibitors for treatment of cancer.
Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
[TBL] [Abstract][Full Text] [Related]
4. The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathway.
Gul N; Karlsson J; Tängemo C; Linsefors S; Tuyizere S; Perkins R; Ala C; Zou Z; Larsson E; Bergö MO; Lindahl P
Sci Rep; 2019 Oct; 9(1):14667. PubMed ID: 31604991
[TBL] [Abstract][Full Text] [Related]
5. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures.
van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O
Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572
[TBL] [Abstract][Full Text] [Related]
6. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E
BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423
[TBL] [Abstract][Full Text] [Related]
7. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS
BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172
[TBL] [Abstract][Full Text] [Related]
8. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of MutT homolog-1 expression on esophageal squamous cell carcinoma.
Akiyama S; Saeki H; Nakashima Y; Iimori M; Kitao H; Oki E; Oda Y; Nakabeppu Y; Kakeji Y; Maehara Y
Cancer Med; 2017 Jan; 6(1):258-266. PubMed ID: 27917618
[TBL] [Abstract][Full Text] [Related]
10. Mitotic MTH1 Inhibitors in Treatment of Cancer.
Helleday T
Cancer Treat Res; 2023; 186():223-237. PubMed ID: 37978139
[TBL] [Abstract][Full Text] [Related]
11. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.
Gad H; Koolmeister T; Jemth AS; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier MC; Desroses M; Gustavsson AL; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KS; Wallner OA; Hammarström LG; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Puigvert JC; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jensen AJ; Artursson P; Nilsson JA; Stenmark P; Scobie M; Berglund UW; Helleday T
Nature; 2014 Apr; 508(7495):215-21. PubMed ID: 24695224
[TBL] [Abstract][Full Text] [Related]
12. MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia.
Sanjiv K; Calderón-Montaño JM; Pham TM; Erkers T; Tsuber V; Almlöf I; Höglund A; Heshmati Y; Seashore-Ludlow B; Nagesh Danda A; Gad H; Wiita E; Göktürk C; Rasti A; Friedrich S; Centio A; Estruch M; Våtsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Mönch K; Garnett MJ; Östling P; Walfridsson J; Helleday T; Warpman Berglund U
Cancer Res; 2021 Nov; 81(22):5733-5744. PubMed ID: 34593524
[TBL] [Abstract][Full Text] [Related]
13. Timing Is Everything: Misincorporation of 8oxodG during Mitosis Is Lethal.
Alnajjar K; Sweasy JB
Cancer Res; 2020 Sep; 80(17):3459-3460. PubMed ID: 32878864
[TBL] [Abstract][Full Text] [Related]
14. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
[TBL] [Abstract][Full Text] [Related]
15. TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells.
Ikejiri F; Honma Y; Kasukabe T; Urano T; Suzumiya J
Oncol Lett; 2018 Mar; 15(3):3240-3244. PubMed ID: 29435064
[TBL] [Abstract][Full Text] [Related]
16. Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry.
Hah SS; Mundt JM; Kim HM; Sumbad RA; Turteltaub KW; Henderson PT
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11203-8. PubMed ID: 17592118
[TBL] [Abstract][Full Text] [Related]
17. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
[TBL] [Abstract][Full Text] [Related]
18. The influence of residue in the position of 116 on the inhibitory potency of TH588 for MTH1.
Niu RJ; Zheng QC; Zhang HX
J Mol Graph Model; 2018 Oct; 85():75-83. PubMed ID: 30103119
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival.
Kawamura T; Kawatani M; Muroi M; Kondoh Y; Futamura Y; Aono H; Tanaka M; Honda K; Osada H
Sci Rep; 2016 May; 6():26521. PubMed ID: 27210421
[TBL] [Abstract][Full Text] [Related]
20. VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells.
Patterson JC; Joughin BA; Prota AE; Mühlethaler T; Jonas OH; Whitman MA; Varmeh S; Chen S; Balk SP; Steinmetz MO; Lauffenburger DA; Yaffe MB
Cell Syst; 2019 Jul; 9(1):74-92.e8. PubMed ID: 31302152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
